Shanghai Jiaoda Onlly Co.,Ltd (SHA:600530)
6.24
-0.10 (-1.58%)
Feb 27, 2026, 3:00 PM CST
SHA:600530 Market Cap
SHA:600530 has a market cap or net worth of 4.84 billion as of February 27, 2026. Its market cap has increased by 36.24% in one year.
Market Cap
4.84B
Enterprise Value
4.92B
Revenue
312.75M
Ranking
n/a
PE Ratio
225.48
Stock Price
6.24
Market Cap Chart
Since July 4, 2001, SHA:600530's market cap has decreased from 6.68B to 4.84B, a decrease of -27.61%. That is a compound annual growth rate of -1.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 4.91B | -1.55% |
| Dec 31, 2025 | 4.99B | 33.33% |
| Dec 31, 2024 | 3.74B | 79.55% |
| Dec 29, 2023 | 2.08B | -29.21% |
| Dec 30, 2022 | 2.94B | -13.83% |
| Dec 31, 2021 | 3.42B | 55.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhuhai Rundu Pharmaceutical | 5.17B |
| Bide Pharmatech | 5.06B |
| Tibet Duo Rui Pharmaceutical | 5.06B |
| Jianmin Pharmaceutical Group | 5.03B |
| Newland Pharmaceutical | 4.97B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.92B |
| Tibet Weixinkang Medicine | 4.84B |
| Shanghai Xiao Fang Pharmaceutical | 4.79B |